Kolexia
Renosi Jennifer
Pharmacien
Hôpital Jean-Minjoz
Besançon, France
31 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Sepsie Choc septique Choc Maladie grave Aspergillose Craniopharyngiome Séquestration bronchopulmonaire Dyslipidémies

Industries

ViiV Healthcare
3 collaboration(s)
Dernière en 2023
OVERCOME
2 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
British journal of clinical pharmacology   21 août 2023
Management of a drug-drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma.
AIDS (London, England)   19 mai 2023
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
The Journal of antimicrobial chemotherapy   03 mars 2023
Proposals for a standardized procedure of validation of DNA extraction and allelic discrimination assays in pharmacogenomics according to ISO15189 requirements.
Pharmacogenetics and genomics   02 mai 2022
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients.
Current HIV research   13 décembre 2021
Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives.
Drug discovery today   01 décembre 2021
β-lactam dosing at the early phase of sepsis: Performance of a pragmatic protocol for target concentration achievement in a prospective cohort study.
Journal of critical care   09 novembre 2021
Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants.
Journal of chemotherapy (Florence, Italy)   26 juin 2021
Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite.
International journal of molecular sciences   31 janvier 2021
Validation of an HPLC-MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice.
Molecules (Basel, Switzerland)   08 janvier 2021